Chaitanya Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.50 Cr
as on 23-10-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.15 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.00 Cr
as on 23-10-2024
- Revenue -74.08%
(FY 2023)
- Profit -6690.88%
(FY 2023)
- Ebitda -185.90%
(FY 2023)
- Net Worth -371.97%
(FY 2023)
- Total Assets 28.97%
(FY 2023)
About Chaitanya Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹6.15 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bipin Shah, Ketan Shah, Samir Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PTC060902
- Company No.
060902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chaitanya Life Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Sharda  | Director | 01-Jun-2021 | Current |
| Paresh Raval | Director | 25-May-2010 | Current |
| Bipin Shah | Director | 01-Jun-2021 | Current |
| Ketan Shah | Director | 01-Jun-2021 | Current |
| Samir Shah | Director | 01-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Chaitanya Life Science.
Chaitanya Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.08% decrease. The company also saw a substantial fall in profitability, with a 6690.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 371.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chaitanya Life Science?
In 2023, Chaitanya Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eskay Iodine Private LimitedActive 13 years 3 monthsBipin Shah, Ketan Shah and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Jul 2017 | ₹6.15 Cr | Open |
Bank Of Baroda Creation Date: 15 Oct 2014 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Chaitanya Life Science?
Chaitanya Life Science has a workforce of 39 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chaitanya Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chaitanya Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
